NYSE:PRGO - Perrigo Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$75.86 +0.22 (+0.29 %)
(As of 06/21/2018 06:55 AM ET)
Previous Close$75.64
Today's Range$75.50 - $76.84
52-Week Range$63.68 - $95.93
Volume877,668 shs
Average Volume1.12 million shs
Market Capitalization$10.47 billion
P/E Ratio15.39
Dividend Yield1.00%
Perrigo logoPerrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations


Debt-to-Equity Ratio0.53
Current Ratio2.08
Quick Ratio1.48


Trailing P/E Ratio15.39
Forward P/E Ratio14.39
P/E Growth1.77

Sales & Book Value

Annual Sales$4.95 billion
Price / Sales2.12
Cash Flow$8.0106 per share
Price / Cash9.47
Book Value$43.81 per share
Price / Book1.73


EPS (Most Recent Fiscal Year)$4.93
Net Income$119.60 million
Net Margins2.59%
Return on Equity11.93%
Return on Assets6.23%


Outstanding Shares138,460,000

Perrigo (NYSE:PRGO) Frequently Asked Questions

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Thursday, May 3rd. Stockholders of record on Friday, June 1st will be given a dividend of $0.19 per share on Tuesday, June 19th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Thursday, May 31st. View Perrigo's Dividend History.

How were Perrigo's earnings last quarter?

Perrigo Company PLC (NYSE:PRGO) released its earnings results on Tuesday, May, 8th. The company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.14 by $0.12. The firm earned $1.22 billion during the quarter, compared to analysts' expectations of $1.21 billion. Perrigo had a net margin of 2.59% and a return on equity of 11.93%. Perrigo's revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.05 EPS. View Perrigo's Earnings History.

When is Perrigo's next earnings date?

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for Perrigo.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY18 earnings guidance on Tuesday, May, 8th. The company provided earnings per share (EPS) guidance of $5.05-5.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.26.

What price target have analysts set for PRGO?

17 brokerages have issued twelve-month price targets for Perrigo's stock. Their forecasts range from $79.00 to $117.00. On average, they anticipate Perrigo's share price to reach $93.6875 in the next year. View Analyst Ratings for Perrigo.

Who are some of Perrigo's key competitors?

Who are Perrigo's key executives?

Perrigo's management team includes the folowing people:
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 58)
  • Mr. Sharon Kochan, Exec. VP & Pres of Consumer Healthcare International (Age 50)
  • Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 62)
  • Mr. Uwe F. Röehrhoff, Pres, CEO & Director (Age 56)
  • Mr. Ronald L. Winowiecki, Chief Financial Officer (Age 52)

Has Perrigo been receiving favorable news coverage?

Media stories about PRGO stock have been trending somewhat positive recently, according to Accern. Accern ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Perrigo earned a coverage optimism score of 0.13 on Accern's scale. They also gave news articles about the company an impact score of 46.37 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are Perrigo's major shareholders?

Perrigo's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.17%), Franklin Resources Inc. (5.86%), Victory Capital Management Inc. (1.75%), Clal Insurance Enterprises Holdings Ltd (1.39%), Manning & Napier Group LLC (1.23%) and Millennium Management LLC (1.02%). Company insiders that own Perrigo stock include Gary K Kunkle Jr, Geoffrey M Parker, Herman Morris Jr, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Sharon Kochan, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

Which institutional investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Migdal Insurance & Financial Holdings Ltd., Sector Gamma AS, Swiss National Bank, Millennium Management LLC, UBS Group AG, Quadrature Capital Ltd and Engineers Gate Manager LP. Company insiders that have sold Perrigo company stock in the last year include Jeffrey Needham, John Wesolowski, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

Which institutional investors are buying Perrigo stock?

PRGO stock was bought by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, Clal Insurance Enterprises Holdings Ltd, Victory Capital Management Inc., New York State Common Retirement Fund, Point72 Asset Management L.P., Franklin Resources Inc., Prudential Financial Inc. and Dimensional Fund Advisors LP. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $75.86.

How big of a company is Perrigo?

Perrigo has a market capitalization of $10.47 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

How can I contact Perrigo?

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]

MarketBeat Community Rating for Perrigo (PRGO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  567 (Vote Outperform)
Underperform Votes:  526 (Vote Underperform)
Total Votes:  1,093
MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.